Back to mobile site
Get it on Google Play

Optimi Health ships first psilocybin export to UK for phase 2 trial

June 10, 2026 2:25 PM EDT Send to a Friend
Optimi Health Corp. (NASDAQ: OPTH) completed its first export of naturally derived psilocybin to the United Kingdom to support a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login